Evidence map›Paper›PMID 20023474›Full record

ArticleCritical care medicine2010

Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsis.

Amisha V Barochia, Xizhong Cui, Charles Natanson, Peter Q Eichacker

Abstract readEditorialComment
In one paragraph

Article in Critical care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2014
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Amisha V Barochia
Xizhong Cui
Charles Natanson
Peter Q Eichacker

Funding

Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cause of DeathLipid ASepsisAnti-Inflammatory AgentsAPACHEClinical Trials, Phase II as TopicCritical CareCritical IllnessFemaleHospital MortalityHumansIntensive Care UnitsMaleMulticenter Studies as TopicPrognosisRandomized Controlled Trials as TopicAnti-Inflammatory AgentsE5564Lipid A

Identifiers

PMID20023474
PMCPMC3523296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.